|
1Q3E
HCN2J 443-645 in the presence of cGMP
Deposited 2003-07-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.239
|
|
1Q3E
HCN2J 443-645 in the presence of cGMP
Deposited 2003-07-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain B
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.239
|
|
1Q3E
HCN2J 443-645 in the presence of cGMP
Deposited 2003-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
Chain B
443–645(203 aa)
Fragment:Residues 443-645 (Reference sequence numbering)
|
Not recorded
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.239
|
|
1Q43
HCN2I 443-640 in the presence of cAMP, selenomethionine derivative
Deposited 2003-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.242
|
|
1Q43
HCN2I 443-640 in the presence of cAMP, selenomethionine derivative
Deposited 2003-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.242
|
|
1Q43
HCN2I 443-640 in the presence of cAMP, selenomethionine derivative
Deposited 2003-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
443–645(203 aa)
Fragment:residues 443-645
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.242
|
|
1Q43
HCN2I 443-640 in the presence of cAMP, selenomethionine derivative
Deposited 2003-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain B
443–645(203 aa)
Fragment:residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å
R-free 0.242
|
|
1Q5O
HCN2J 443-645 in the presence of cAMP, selenomethionine derivative
Deposited 2003-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–645(203 aa)
Fragment:Residues 443-645
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;PEG 400, sodium citrate, sodium chloride, DTT, HEPES, cAMP, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.261
|
|
2Q0A
Structure and rearrangements in the carboxy-terminal region of SpIH channels
Deposited 2007-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å
R-free 0.261
|
|
2Q0A
Structure and rearrangements in the carboxy-terminal region of SpIH channels
Deposited 2007-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å
R-free 0.261
|
|
2Q0A
Structure and rearrangements in the carboxy-terminal region of SpIH channels
Deposited 2007-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D
Mutation:I636D
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å
R-free 0.261
|
|
2Q0A
Structure and rearrangements in the carboxy-terminal region of SpIH channels
Deposited 2007-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain B
443–640(198 aa)
Fragment:C-TERMINAL DOMAIN (residues 443-640)
|
Mutation:I636D
|
PCG CYCLIC GUANOSINE MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;10 % w/v PEG 8000, 0.5 M NaCl, 15 % Glycerol, 0.1 M MES, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.25 Å
R-free 0.261
|
|
3BPZ
HCN2-I 443-460 E502K in the presence of cAMP
Deposited 2007-12-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain B
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain C
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
Chain D
443–640(198 aa)
Fragment:ligand biding domain (residues 443-640)
|
Mutation:E502K
Mutation:E502K
Mutation:E502K
Mutation:E502K
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 4.6;279 K;PEG 400, SODIUM CITRATE, SODIUM CHLORIDE, DTT, HEPES, 5 mM CAMP, pH 4.6, VAPOR DIFFUSION, temperature 279K
|
Resolution 1.65 Å
R-free 0.216
|
|
3ETQ
X-ray structure of cysteine-free fragment of mHCN2 C-terminal region from amino acids 443-630 including C508N, C584S, and C601S mutations
Deposited 2008-10-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
443–640(198 aa)
Fragment:C-terminal fragment
Chain B
443–640(198 aa)
Fragment:C-terminal fragment
|
Mutation:C508N, C584S, C601S
Mutation:C508N, C584S, C601S
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;16% w/v PEG 6000, 500 mM NaCl, 10% glycerol, 100 mM citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.216
|
|
3FFQ
HCN2I 443-640 apo-state
Deposited 2008-12-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–640(198 aa)
|
Not recorded
|
BR BROMIDE ION × 20
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Two uL protein (5-7 mg/mL) mixed with one uL reservoir solution composed of 0.4 M NaCl, 0.1 NaBr, 0.1 M MES, pH 6.0, 20% glycerol (v/v), and 20% PEG 8000 (w/v). Crystals grew within eight weeks and harvested an additional eight weeks after initial growth, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å
R-free 0.283
|
|
3FFQ
HCN2I 443-640 apo-state
Deposited 2008-12-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain B
443–640(198 aa)
|
Not recorded
|
BR BROMIDE ION × 16
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Two uL protein (5-7 mg/mL) mixed with one uL reservoir solution composed of 0.4 M NaCl, 0.1 NaBr, 0.1 M MES, pH 6.0, 20% glycerol (v/v), and 20% PEG 8000 (w/v). Crystals grew within eight weeks and harvested an additional eight weeks after initial growth, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å
R-free 0.283
|
|
5JON
Crystal structure of the unliganded form of HCN2 CNBD
Deposited 2016-05-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
494–640(147 aa)
|
Not recorded
|
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;34-36% dimethyl PEG 500, 240 mM potassium nitrate, 20 mM magnesium chloride, 100 mM BIS-TRIS, pH 6.0
|
Resolution 2.04 Å
R-free 0.221
|
|
5JON
Crystal structure of the unliganded form of HCN2 CNBD
Deposited 2016-05-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
494–640(147 aa)
|
Not recorded
|
NO3 NITRATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;34-36% dimethyl PEG 500, 240 mM potassium nitrate, 20 mM magnesium chloride, 100 mM BIS-TRIS, pH 6.0
|
Resolution 2.04 Å
R-free 0.221
|
|
5KHG
HCN2 CNBD in complex with cytidine-3', 5'-cyclic monophosphate (cCMP)
Deposited 2016-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CC7 4-amino-1-[(2S,4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]pyrimidin-2(1H)-one × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.0, 16% PEG 400
|
Resolution 2.24 Å
R-free 0.264
|
|
5KHH
HCN2 CNBD in complex with inosine-3', 5'-cyclic monophosphate (cIMP)
Deposited 2016-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
6SW Inosine-3',5'-cyclic monophosphate × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.5, 14.5% PEG 400
|
Resolution 1.77 Å
R-free 0.263
|
|
5KHI
HCN2 CNBD in complex with purine riboside-3', 5'-cyclic monophosphate (cPuMP)
Deposited 2016-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
6SX Purine riboside-3',5'-cyclic monophosphate × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 5.5, 18% PEG 400
|
Resolution 2.10 Å
R-free 0.249
|
|
5KHJ
HCN2 CNBD in complex with uridine-3', 5'-cyclic monophosphate (cUMP)
Deposited 2016-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
Chain B
443–643(201 aa)
Fragment:UNP residues 443-643
|
Not recorded
|
6SY Uridine-3',5'-cyclic monophosphate × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 4.6, 13% PEG 400
|
Resolution 2.01 Å
R-free 0.252
|
|
5KHK
HCN2 CNBD in complex with 2-aminopurine riboside-3', 5'-cyclic monophosphate (2-NH2-cPuMP)
Deposited 2016-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
443–643(201 aa)
Fragment:UNP residues 443-643
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
6SZ 2-Aminopurine riboside-3',5'-cyclic monophosphate × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;277 K;200 mM NaCl, 0.1 mM sodium citrate pH 4.6, 12% PEG 400
|
Resolution 2.07 Å
R-free 0.261
|
|
9R1T
Structure of the human chimera HCN112 hyperpolarization-activated cyclic nucleotide-gated ion channel in complex with cAMP.
Deposited 2025-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
444–647(204 aa)
Chain B
444–647(204 aa)
Chain C
444–647(204 aa)
Chain D
444–647(204 aa)
|
Not recorded
|
CMP ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.34 Å
|